Apolipoprotein E (apo E) is a major plasma apolipoprotein found in both very low density and high density (HDL) lipoproteins. Apo E appears to be an important components of the reverse cholesterol transport system that delivers cholesterol from peripheral tissues to the liver for metabolism. Recent evidence indicated that apo E is synthesized in peripheral tissues as well as in the liver. The purpose of the present research is to determine the significance of peripheral apo E synthesis as it relates to reverse cholesterol transport and atherosclerosis. Toward this end, five specific questions have been identified. First, in which peripheral tissues is apo E made? These experiments will employ short-term organ-culture with radiolabeled amino acid and specific immunoprecipitation to identify newly synthesized apo E. Second, how much apo E is made in peripheral tissues as compared to the liver? These experiments will use a cDNA clone to apo E to determine the absolute apo E mRNA content in the liver and peripheral tissues. Third, which cells in peripheral tissues make apo E? These experiments will use a cDNA clone to apo E as a hisotlogical reagent for in situ hybridization to identify cells which contain apo E mRNA. Fourth, is apo E synthesis in peripheral cells regulated in the same fashion as in the liver? These experiments involve an analysis of apo E mRNA via S1 nuclease unapping, northern gel analysis, and primer extension procedures. Fifth, how are peripheral and hepatic apo E synthesis related to diet-induced changes in plasma lipoportiens and atherosclerosis. The experiments described above will be carried out with tissues from animals that are part of a long term study by other investigators on diet and atherosclerosis. As a result it will be possible to correlate the findings on peripheral apo E with diet-induced changes in lipoproteins and vascular disease. the long range goal of th is work is to elluciadate the functional nature of peripheral apo E as it relates to reverse cholesterol transport and atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032868-05
Application #
3344399
Study Section
Metabolism Study Section (MET)
Project Start
1984-06-01
Project End
1989-05-31
Budget Start
1988-06-01
Budget End
1989-05-31
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Ma, Yanqing; Malbon, Craig C; Williams, David L et al. (2008) Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein E. PLoS One 3:e2503
Zhao, Yue; Thorngate, Fayanne E; Weisgraber, Karl H et al. (2005) Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins. Biochemistry 44:1013-25
Mann, Karen M; Thorngate, Fayanne E; Katoh-Fukui, Yuko et al. (2004) Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model. Hum Mol Genet 13:1959-68
Wientgen, Hilke; Thorngate, Fayanne E; Omerhodzic, Sabina et al. (2004) Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 24:1460-5
Temel, Ryan E; Parks, John S; Williams, David L (2003) Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase. J Biol Chem 278:4792-9
Thorngate, Fayanne E; Yancey, Patricia G; Kellner-Weibel, Ginny et al. (2003) Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression. J Lipid Res 44:2331-8
Thorngate, Fayanne E; Strockbine, Penelope A; Erickson, Sandra K et al. (2002) Altered adrenal gland cholesterol metabolism in the apoE-deficient mouse. J Lipid Res 43:1920-6
Swarnakar, S; Beers, J; Strickland, D K et al. (2001) The apolipoprotein E-dependent low density lipoprotein cholesteryl ester selective uptake pathway in murine adrenocortical cells involves chondroitin sulfate proteoglycans and an alpha 2-macroglobulin receptor. J Biol Chem 276:21121-8
DeMattos, R B; Rudel, L L; Williams, D L (2001) Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. J Lipid Res 42:976-87
Thorngate, F E; Rudel, L L; Walzem, R L et al. (2000) Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 20:1939-45

Showing the most recent 10 out of 55 publications